{
    "title": "109_hr5116",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Choice for America's Seniors Act of \n2006''.\n\nSEC. 2. SIX-MONTH EXTENSION OF 2006 INITIAL ENROLLMENT PERIOD FOR \n              MEDICARE PRESCRIPTION DRUG PLANS AND MA PLANS.\n\n    (a) In General.--Section 1851(e)(3)(B)(iii) of the Social Security \nAct (42 U.S.C. 1395w-21(e)(3)(B)(iii)) is amended by striking ``May 15, \n2006'' and inserting ``November 14, 2006''.\n    (b) Effective Date.--The amendments made by this section shall take \neffect as if included in the enactment of the Medicare Prescription \nDrug, Improvement, and Modernization Act of 2003 (Public Law 108-173).\n\nSEC. 3. SUSPENSION OF MEDICARE PRESCRIPTION DRUG LATE ENROLLMENT \n              PENALTY DURING 2006.\n\n    (a) In General.--Section 1860D-13(b)(3)(B) of the Social Security \nAct (42 U.S.C. 1395w-113(b)(3)(B)) is amended by inserting ``(after \nDecember 2006)'' after ``any month''.\n    (b) Effective Date.--The amendments made by this section shall take \neffect as if included in the enactment of the Medicare Prescription \nDrug, Improvement, and Modernization Act of 2003 (Public Law 108-173).\n\nSEC. 4. CHANGES OF ENROLLMENT IN PRESCRIPTION DRUG PLANS AND MA PLANS \n              ALLOWED TWICE DURING YEAR.\n\n    (a) Additional Election Permitted Once Each Year Outside of Annual \nCoordinated Election Period.--Section 1851(e)(4) of the Social Security \nAct (42 U.S.C. 1395w-21(e)(4)) is amended by inserting ``once every \nyear, and in addition,'' after ``make a new election under this \nsection''.\n    (b) Effective Date.--The amendment made by subsection (a) shall \ntake effect as of the date of the enactment of this Act.\n\nSEC. 5. LIMITATION ON REMOVAL OR CHANGE OF COVERED PART D DRUGS FROM \n              THE PRESCRIPTION DRUG PLAN FORMULARY; NOTICE OF CHANGES \n              IN COVERAGE.\n\n    (a) Limitation on Removal or Change of Covered Part D Drugs From \nthe Prescription Drug Plan Formulary.--Section 1860D-4(b)(3)(E) of the \nSocial Security Act (42 U.S.C. 1395w-104(b)(3)(E)) is amended to read \nas follows:\n                    ``(E) Removing a drug from formulary or imposing a \n                restriction or limitation on coverage.--\n                            ``(i) Limitation on removal, limitation, or \n                        restriction.--\n                                    ``(I) In general.--Subject to \n                                subclause (II) and clause (ii), \n                                beginning with 2006, the PDP sponsor of \n                                a prescription drug plan may not remove \n                                a covered part D drug from the plan \n                                formulary or impose a restriction or \n                                limitation on the coverage of such a \n                                drug (such as through the application \n                                of a preferred status, usage \n                                restriction, step therapy, prior \n                                authorization, or quantity limitation) \n                                other than at the beginning of each \n                                plan year except as the Secretary may \n                                permit to take into account new \n                                therapeutic uses and newly covered part \n                                D drugs.\n                                    ``(II) Special rule for newly \n                                enrolled individuals.--Subject to \n                                clause (ii), in the case of an \n                                individual who enrolls in a \n                                prescription drug plan on or after the \n                                date of enactment of this subparagraph, \n                                the PDP sponsor of such plan may not \n                                remove a covered part D drug from the \n                                plan formulary or impose a restriction \n                                or limitation on the coverage of such a \n                                drug (such as through the application \n                                of a preferred status, usage \n                                restriction, step therapy, prior \n                                authorization, or quantity limitation) \n                                during the period beginning on the date \n                                of such enrollment and ending on \n                                December 31 of the immediately \n                                succeeding plan year except as the \n                                Secretary may permit to take into \n                                account new therapeutic uses and newly \n                                covered part D drugs.\n                            ``(ii) Exceptions to limitation on \n                        removal.--Clause (i) shall not apply with \n                        respect to a covered part D drug that--\n                                    ``(I) is a brand name drug for \n                                which there is a generic drug approved \n                                under section 505(j) of the Food and \n                                Drug Cosmetic Act (21 U.S.C. 355(j)) \n                                that is placed on the market during the \n                                period in which there are limitations \n                                on removal or change in the formulary \n                                under subclause (I) or (II) of clause \n                                (i) if such generic drug is included in \n                                the formulary without any restriction \n                                or limitation placed on the coverage of \n                                such generic drug other than a \n                                restriction or limitation that would be \n                                placed on the coverage of the brand \n                                name drug during such period without \n                                the application of this clause;\n                                    ``(II) is a brand name drug that \n                                goes off-patent during such period;\n                                    ``(III) is a drug for which the \n                                Commissioner of Food and Drugs issues a \n                                clinical warning that imposes a \n                                restriction or limitation on the drug \n                                during such period;\n                                    ``(IV) is a drug that the \n                                appropriate pharmacy and therapeutic \n                                committee determines, based on evidence \n                                from peer-reviewed medical research, to \n                                be unsafe or ineffective during such \n                                period; or\n                                    ``(V) is any other drug that \n                                satisfies any other requirement \n                                determined appropriate by the \n                                Secretary.\n                            ``(iii) Notice of removal under application \n                        of exception to limitation.--Not later than 90 \n                        days before a PDP sponsor of a prescription \n                        drug plan removes a covered part D drug from \n                        the plan formulary (or restricts or limits such \n                        coverage) under clause (ii), the sponsor shall \n                        provide appropriate notice (such as under \n                        subsection (a)(3)) of such removal (or \n                        restriction or limitation) to the Secretary, \n                        affected enrollees, physicians, pharmacies, and \n                        pharmacists.''.\n    (a) Advance Notice Required for Change in Formulary and Other \nRestrictions or Limitations on Coverage.--\n            (1) In general.--Section 1860D-4(a) of the Social Security \n        Act (42 U.S.C. 1395w-104(a)) is amended by adding at the end \n        the following new paragraph:\n            ``(5) Annual notice of changes in formulary and other \n        restrictions or limitations on coverage.--Each PDP sponsor \n        offering a prescription drug plan shall furnish to each \n        enrollee 90 days before the time of each annual coordinated \n        election period (referred to in section 1860D-1(b)(1)(B)(iii)) \n        for a plan year a notice of any changes in the formulary or \n        other restrictions or limitations on coverage of a covered part \n        D drug under the plan that will take effect for the plan \n        year.''.\n            (2) Effective date.--The amendment made by paragraph (1) \n        shall apply to annual coordinated election periods beginning \n        after the date of the enactment of this Act, except that if \n        this Act is enacted after September 15, 2006, and before \n        January 1, 2007, the notice required under such section shall \n        apply with respect to the annual coordinated election period \n        that begins on November 15, 2006, as of such date (as soon as \n        possible after such date of enactment) as the Secretary of \n        Health and Human Services shall specify."
}